Advertisement

Journal of Nuclear Cardiology

, Volume 22, Issue 5, pp 1041–1144 | Cite as

2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials

A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards)
ACC/AHA Clinical Data Standards

Keywords AHA Scientific Statements, clinical trials, cardiovascular endpoints, clinical events, death, myocardial infarction, stroke, percutaneous coronary intervention, peripheral vascular intervention, heart failure, unstable angina

WRITING COMMITTEE MEMBERS*

Karen A. Hicks, MD, FACC, Chair*; James E. Tcheng, MD, FACC, Vice-Chair; Biykem Bozkurt, MD, PhD, FACC, FAHA; Bernard R. Chaitman, MD, FACC; Donald E. Cutlip, MD, FACC; Andrew Farb, MD, FACC*; Gregg C. Fonarow, MD, FACC, FAHA; Jeffrey P. Jacobs, MD, FACC; Michael R. Jaff, DO, FACC; Judith H. Lichtman, MPH, PhD; Marian C. Limacher, MD, FACC, FAHA; Kenneth W. Mahaffey, MD, FACC; Roxana Mehran, MD, FACC, FAHA; Steven E. Nissen, MD, MACC, FAHA; Eric E. Smith, MD, MPH, FAHA; Shari L. Targum, MD, FACC*

ACC/AHA TASK FORCE ON CLINICAL DATA STANDARDS MEMBERS

William S. Weintraub, MD, MACC, FAHA, Chair; Biykem Bozkurt, MD, PhD, FACC, FAHA; Gregg C. Fonarow, MD, FACC, FAHA; Robert C. Hendel, MD, FACC, FAHA†; Jeffrey P. Jacobs, MD, FACC;...

References

  1. 1.
    Health Insurance Portability and Accountability Act of 1996. Public Law 104-191. 1996.Google Scholar
  2. 2.
    Hammond WE. Seamless care: what is it; what is its value; what does it require; when might we get it? Stud Health Technol Inform. 2010;155:3–13.PubMedGoogle Scholar
  3. 3.
    Cimino JJ. Desiderata for controlled medical vocabularies in the twenty-first century. Methods Inf Med. 1998;37:394–403.PubMedCentralPubMedGoogle Scholar
  4. 4.
    Hicks KA, Hung HM, Mahaffey KW, et al. Standardized Definitions for Cardiovascular and Stroke End Point Events in Clinical Trials. Available at: http://www.cdisc.org/therapeutic. Accessed August 20, 2014.
  5. 5.
    Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): Developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons. Circulation. 2007;116:e148–304.CrossRefPubMedGoogle Scholar
  6. 6.
    Campeau L. Letter: grading of angina pectoris. Circulation. 1976;54:522–3.PubMedGoogle Scholar
  7. 7.
    Cutlip DE, Windecker S, Mehran R, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115:2344–51.CrossRefPubMedGoogle Scholar
  8. 8.
    Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA). Eur J Heart Fail. 2008;10:933–89.CrossRefPubMedGoogle Scholar
  9. 9.
    Easton JD, Saver JL, Albers GW, et al. Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. Stroke. 2009;40:2276–93.CrossRefPubMedGoogle Scholar
  10. 10.
    Hiatt WR, Goldstone J, Smith SC Jr, et al. Atherosclerotic Peripheral Vascular Disease Symposium II: nomenclature for vascular diseases. Circulation. 2008;118:2826–9.CrossRefPubMedGoogle Scholar
  11. 11.
    Hunt SA, Abraham WT, Chin MH, et al. 2009 Focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation. 2009;119:e391–479.CrossRefPubMedGoogle Scholar
  12. 12.
    Jneid H, Anderson JL, Wright RS, et al. 2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2012;126:875–910.CrossRefPubMedGoogle Scholar
  13. 13.
    Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. Circulation. 2012;126:2020–35.CrossRefPubMedGoogle Scholar
  14. 14.
    Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012;60:1581–98.CrossRefPubMedGoogle Scholar
  15. 15.
    Hendel RC, Bozkurt B, Fonarow GC, et al. ACC/AHA 2013 methodology for developing clinical data standards: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards. Circulation. 2014;129:2346–57.CrossRefPubMedGoogle Scholar
  16. 16.
    Cannon CP, Brindis RG, Chaitman BR, et al. 2013 ACCF/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes and coronary artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Acute Coronary Syndromes and Coronary Artery Disease Clinical Data Standards). Circulation. 2013;127:1052–89.CrossRefPubMedGoogle Scholar
  17. 17.
    Creager MA, Belkin M, Bluth EI, et al. 2012 ACCF/AHA/ACR/SCAI/SIR/STS/SVM/SVN/SVS key data elements and definitions for peripheral atherosclerotic vascular disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (Writing Committee to develop Clinical Data Standards for Peripheral Atherosclerotic Vascular Disease). Circulation. 2012;125:395–467.CrossRefPubMedGoogle Scholar
  18. 18.
    O’Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127:529–55.CrossRefPubMedGoogle Scholar
  19. 19.
    Sacco RL, Kasner SE, Broderick JP, et al. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44:2064–89.CrossRefPubMedGoogle Scholar
  20. 20.
    Weintraub WS, Karlsberg RP, Tcheng JE, et al. ACCF/AHA 2011 key data elements and definitions of a base cardiovascular vocabulary for electronic health records: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards. Circulation. 2011;124:103–23.CrossRefPubMedGoogle Scholar
  21. 21.
    Zannad F, Garcia AA, Anker SD, et al. Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document. Eur J Heart Fail. 2013;15:1082–94.CrossRefPubMedGoogle Scholar
  22. 22.
    Lloyd-Jones DM, Martin DO, Larson MG, et al. Accuracy of death certificates for coding coronary heart disease as the cause of death. Ann Intern Med. 1998;129:1020–6.CrossRefPubMedGoogle Scholar
  23. 23.
    Every NR, Parsons L, Hlatky MA, et al. Use and accuracy of state death certificates for classification of sudden cardiac deaths in high-risk populations. Am Heart J. 1997;134:1129–32.CrossRefPubMedGoogle Scholar
  24. 24.
    Moussa ID, Klein LW, Shah B, et al. Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI). J Am Coll Cardiol. 2013;62:1563–70.PubMedCentralCrossRefPubMedGoogle Scholar
  25. 25.
    White H. Avatar of the universal definition of periprocedural myocardial infarction. J Am Coll Cardiol. 2013;62:1571–4.CrossRefPubMedGoogle Scholar
  26. 26.
    Rankin J. Cerebral vascular accidents in patients over the age of 60. II. Prognosis. Scott Med J. 1957;2:200–15.PubMedGoogle Scholar
  27. 27.
    Ives DG, Fitzpatrick AL, Bild DE, et al. Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study. Ann Epidemiol. 1995;5:278–85.PubMedGoogle Scholar
  28. 28.
    Binanay C, Califf RM, Hasselblad V, et al. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA. 2005;294:1625–33.CrossRefPubMedGoogle Scholar
  29. 29.
    Butman SM, Ewy GA, Standen JR, et al. Bedside cardiovascular examination in patients with severe chronic heart failure: importance of rest or inducible jugular venous distension. J Am Coll Cardiol. 1993;22:968–74.CrossRefPubMedGoogle Scholar
  30. 30.
    Dao Q, Krishnaswamy P, Kazanegra R, et al. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J Am Coll Cardiol. 2001;37:379–85.CrossRefPubMedGoogle Scholar
  31. 31.
    Davis M, Espiner E, Richards G, et al. Plasma brain natriuretic peptide in assessment of acute dyspnoea. Lancet. 1994;343:440–4.CrossRefPubMedGoogle Scholar
  32. 32.
    Drazner MH, Rame JE, Stevenson LW, et al. Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. N Engl J Med. 2001;345:574–81.CrossRefPubMedGoogle Scholar
  33. 33.
    Drazner MH, Hellkamp AS, Leier CV, et al. Value of clinician assessment of hemodynamics in advanced heart failure: the ESCAPE trial. Circ Heart Fail. 2008;1:170–7.PubMedCentralCrossRefPubMedGoogle Scholar
  34. 34.
    Kirkpatrick JN, Vannan MA, Narula J, et al. Echocardiography in heart failure: applications, utility, and new horizons. J Am Coll Cardiol. 2007;50:381–96.CrossRefPubMedGoogle Scholar
  35. 35.
    Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347:161–7.CrossRefPubMedGoogle Scholar
  36. 36.
    Moe GW, Howlett J, Januzzi JL, et al. N-terminal pro-B-type natriuretic peptide testing improves the management of patients with suspected acute heart failure: primary results of the Canadian prospective randomized multicenter IMPROVE-CHF study. Circulation. 2007;115:3103–10.CrossRefPubMedGoogle Scholar
  37. 37.
    Mueller C, Scholer A, Laule-Kilian K, et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med. 2004;350:647–54.CrossRefPubMedGoogle Scholar
  38. 38.
    Nagueh SF, Appleton CP, Gillebert TC, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr. 2009;10:165–93.CrossRefPubMedGoogle Scholar
  39. 39.
    Nagueh SF, Bhatt R, Vivo RP, et al. Echocardiographic evaluation of hemodynamics in patients with decompensated systolic heart failure. Circ Cardiovasc Imaging. 2011;4:220–7.CrossRefPubMedGoogle Scholar
  40. 40.
    van Kimmenade RR, Pinto YM, Bayes-Genis A, et al. Usefulness of intermediate amino-terminal pro-brain natriuretic peptide concentrations for diagnosis and prognosis of acute heart failure. Am J Cardiol. 2006;98:386–90.CrossRefPubMedGoogle Scholar
  41. 41.
    Austen WG, Edwards JE, Frye RL, et al. A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation. 1975;51:5–40.CrossRefPubMedGoogle Scholar
  42. 42.
    Alderman EL, Stadius M. The angiographic definitions of the bypass angioplasty revascularization investigation. Coronary Artery Disease. 1992;3:1189–207.Google Scholar
  43. 43.
    Louvard Y, Thomas M, Dzavik V, et al. Classification of coronary artery bifurcation lesions and treatments: time for a consensus! Catheter Cardiovasc Interv. 2008;71:175–83.CrossRefPubMedGoogle Scholar
  44. 44.
    Medina A. Suarez de Lezo J., Pan M. [A new classification of coronary bifurcation lesions]. Rev Esp Cardiol. 2006;59:183.CrossRefPubMedGoogle Scholar
  45. 45.
    Hammond WE. eHealth interoperability. Stud Health Technol Inform. 2008;134:245–53.PubMedGoogle Scholar
  46. 46.
    Mead CN. Data interchange standards in healthcare IT–computable semantic interoperability: now possible but still difficult, do we really need a better mousetrap? J Healthc Inf Manag. 2006;20:71–8.PubMedGoogle Scholar
  47. 47.
    Fragoso G, de Coronado S, Haber M, et al. Overview and utilization of the NCI thesaurus. Comp Funct Genomics. 2004;5:648–54.PubMedCentralCrossRefPubMedGoogle Scholar
  48. 48.
    Komatsoulis GA, Warzel DB, Hartel FW, et al. caCORE version 3: implementation of a model driven, service-oriented architecture for semantic interoperability. J Biomed Inform. 2008;41:106–23.PubMedCentralCrossRefPubMedGoogle Scholar
  49. 49.
    CDISC Glossary. Available at: http://cdisc.org/therapeutic. Accessed December 12, 2014.
  50. 50.
    LOINC Test. Available at: http://www.loinc.org. Accessed December 12, 2014.
  51. 51.
    van Swieten JC, Koudstaal PJ, Visser MC, et al. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19:604–7.CrossRefPubMedGoogle Scholar
  52. 52.
    Radford MJ, Arnold JM, Bennett SJ, et al. ACC/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with chronic heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Heart Failure Clinical Data Standards). Developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation. Circulation. 2005;112:1888–916.CrossRefPubMedGoogle Scholar
  53. 53.
    NCDR CathPCI Registry v4.4 Coder’s Data Dictionary. Available at: https://www.ncdr.com/WebNCDR/docs/public-data-collection-documents/www.cathpci_v4_codersdictionary_4-4.pdf?sfvrsn=2. Accessed December 12, 2014.
  54. 54.
    Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2011;56:e574–651.Google Scholar
  55. 55.
    Butman SM, editor. Complications of Percutaneous Coronary Interventions. New York, NY: Springer; 2010.Google Scholar
  56. 56.
    National Heart, Lung, and Blood Institute. Coronary artery angiographic changes after percutaneous transluminal coronary angioplasty. In: Manual of Operations: NHLBI PTCA Registry. Bethesda, MD: National Heart, Lung, and Blood Institute; 1985:6–9.Google Scholar
  57. 57.
    Capone G, Wolf NM, Meyer B, et al. Frequency of intracoronary filling defects by angiography in angina pectoris at rest. Am J Cardiol. 1985;56:403–6.CrossRefPubMedGoogle Scholar
  58. 58.
    Cannon CP, Braunwald E, McCabe CH, et al. The Thrombolysis in Myocardial Infarction (TIMI) trials: the first decade. J Interv Cardiol. 1995;8:117–35.CrossRefPubMedGoogle Scholar
  59. 59.
    STS/ACC TVT Registry v2.0 Coder’s Data Dictionary. Available at: https://www.ncdr.com/TVT/Libraries/TVT_Library/2_0_CoderDataDictionary.sflb.ashx. Accessed December 12, 2014.
  60. 60.
    Diehm N, Pattynama PM, Jaff MR, et al. Clinical endpoints in peripheral endovascular revascularization trials: a case for standardized definitions. Eur J Vasc Endovasc Surg. 2008;36:409–19.CrossRefPubMedGoogle Scholar

Copyright information

© American College of Cardiology Foundation and American Heart Association, Inc 2015

Personalised recommendations